4th Quarter - Report

AMERICAN COLLEGE OF CARDIOLOGY for AMERICAN COLLEGE OF CARDIOLOGY

Firm
Client
Income
—
Expenses
$450,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Tobacco TOB

Tobacco use prevention and smoking cessation; FDA regulation of tobacco; electronic cigarettes and nicotine products; tobacco and electronic cigarette policy in House and Senate Ap420propriations; Tobacco Tax Equity Act of 2021 (HR 2786/S. 1314)

Contacted: SENATE; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; White House Office; Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1314 (117th), H.R. 2786 (117th)

Health Issues HCR

Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; clinical data registries including HR 5394, Meaningful Access to Federal Health Plan Claims Data Act of 2021; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, FDA, HRSA and the Childrens Hospital Graduate Medical Education payment program, the Prevention & Public Health Fund, medical research, and prevention; research and scholarly communication policy; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; reduction/oversight of prior authorization and other administrative burdens; digital health; cardiomyopathy education and awareness; peripheral arterial disease (PAD) education and awareness; research on valvular heart disease including the CAROL Act (HR 1193/ S. 1133); VA Mission Act implementation; COVID-19 and implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, the Families First Coronavirus Response Act , the Coronavirus Aid, Relief, and Economic Security Act, Coronavirus Provider Protection Act (HR 3021), and clinician mental health including the Dr. Lorna Breen Health Care Provider Protection Act (HR 1667/S 610); patient identification

Contacted: Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); White House Office; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC)

Bills named: H.R. 1667 (117th), H.R. 1193 (117th), S. 1133 (117th), H.R. 5394 (117th), H.R. 3021 (117th)

Medicare/Medicaid MMM

Medicare physician payment; new/alternative payment models; Medicare coverage, hospital payment of cardiovascular services; access to Medicare claims data; physician and hospital quality; Quality Payment Program; clinical data registries; health care quality; medical imaging and prior authorization; the Stark Law and the in-office ancillary services exception; Medicare Access and CHIP Reauthorization Act implementation and oversight; Bipartisan Budget Act of 2015 and Medicare site of service policy; access to and supervision of Cardiac and Pulmonary Rehabilitation (HR 1956/ S. 1986); graduate medical education policy including the Resident Physician Shortage Reduction Act of 2021 (HR 2256/S 834); oversight and implementation of the Protecting Access to Medicare Act of 2014, including Appropriate Use Criteria; physician-owned hospital policy; COVID-19 public health emergency and the implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, the Families First Coronavirus Response Act, the Coronavirus Aid, Relief, and Economic Security Act; Protecting Access to Post-COVID-19 Telehealth Act (HR 366); Medicare Stability for Patients and Providers Act (HR 6048); Protecting Medicare and American Farmers from Sequester Cuts Act (S 610)

Contacted: Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Natl Institutes of Health (NIH); White House Office; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1956 (117th), H.R. 6048 (117th), S. 1986 (117th), H.R. 366 (117th), H.R. 2256 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.